Symbols / HSCS $2.20 -2.65% HeartSciences Inc.
HSCS Chart
About
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 7.01M |
| Enterprise Value | 7.67M | Income | -8.49M | Sales | 8.67K |
| Book/sh | 0.83 | Cash/sh | 1.07 | Dividend Yield | — |
| Payout | 0.00% | Employees | 15 | IPO | — |
| P/E | — | Forward P/E | -0.78 | PEG | — |
| P/S | 808.21 | P/B | 2.64 | P/C | — |
| EV/EBITDA | -0.99 | EV/Sales | 884.58 | Quick Ratio | 0.80 |
| Current Ratio | 1.19 | Debt/Eq | 145.81 | LT Debt/Eq | — |
| EPS (ttm) | -4.49 | EPS next Y | -2.83 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-16 16:00 | ROA | -73.51% |
| ROE | -3.82% | ROIC | — | Gross Margin | 57.92% |
| Oper. Margin | -899.40% | Profit Margin | 0.00% | Shs Outstand | 3.18M |
| Shs Float | 3.07M | Short Float | 1.04% | Short Ratio | 3.42 |
| Short Interest | — | 52W High | 6.47 | 52W Low | 2.01 |
| Beta | 2.45 | Avg Volume | 20.21K | Volume | 12.28K |
| Target Price | $10.00 | Recom | Strong_buy | Prev Close | $2.26 |
| Price | $2.20 | Change | -2.65% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$10.00
Mean price target
2. Current target
$2.20
Latest analyst target
3. DCF / Fair value
$-23.81
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.20
Low
$8.00
High
$12.00
Mean
$10.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-24 | main | Ascendiant Capital | Buy → Buy | $8 |
| 2025-12-22 | main | Ascendiant Capital | Buy → Buy | $9 |
| 2025-10-01 | main | Ascendiant Capital | Buy → Buy | $9 |
| 2025-03-18 | main | Ascendiant Capital | Buy → Buy | $14 |
| 2024-12-18 | reit | Maxim Group | Buy → Buy | $12 |
| 2024-09-23 | reit | Ascendiant Capital | Buy → Buy | $15 |
| 2023-01-30 | init | Ascendiant Capital | — → Buy | $3 |
| 2022-12-19 | main | Maxim Group | — → Buy | $3 |
| 2022-11-09 | init | Maxim Group | — → Buy | $8 |
| 2022-08-08 | init | Benchmark | — → Speculative Buy | $8 |
- HeartSciences (HSCS) announces death of COO and director, affirms business plans - Stock Titan Fri, 03 Apr 2026 21
- New Analyst Forecast: $HSCS Given $8 Price Target - Quiver Quantitative ue, 24 Mar 2026 07
- AI Models Flag HSCS as High-Risk Play Despite Theoretical Upside - TipRanks Sun, 05 Apr 2026 13
- HSCS Receives Analyst Rating Update: Price Target Lowered by Asc - GuruFocus ue, 24 Mar 2026 07
- Should I buy HeartSciences Inc. (HSCS) - Zacks Investment Research ue, 21 Oct 2025 07
- Can HeartSciences Stock Recover If Markets Fall? - Trefis Mon, 22 Dec 2025 08
- HeartSciences lands Epic Toolbox spot for ECG workflow software - Stock Titan Wed, 25 Mar 2026 07
- HeartSciences Secures New Private Financing Through Note Issuance - The Globe and Mail Sat, 17 Jan 2026 08
- HeartSciences COO and Longtime Board Member Passes Away - TipRanks Fri, 03 Apr 2026 21
- HeartSciences reports passing of COO Mark Hilz, will not seek immediate replacement - uk.investing.com Fri, 03 Apr 2026 22
- symbol__ Stock Quote Price and Forecast - CNN Mon, 12 Feb 2024 17
- AI heart scans in the cloud: HeartSciences builds ECG marketplace for hospitals - Stock Titan Mon, 16 Mar 2026 07
- HeartSciences Inc. Reports Second Quarter Fiscal 2026 Financial Results and Progress on MyoVista Insights and wavECG Device Submissions | HSCS Stock News - Quiver Quantitative Mon, 15 Dec 2025 08
- HeartSciences CEO to outline strategy in virtual investor meetings - Stock Titan ue, 24 Mar 2026 07
- HeartSciences Inc. Reports Fiscal Third Quarter 2026 Financial Results and Progress on MyoVista Insights™ Platform - Quiver Quantitative Mon, 16 Mar 2026 07
Financials
Statement View
| Line Item | Trend | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
-76.61%
|
0.02
+261.17%
|
0.01
-64.17%
|
0.01
|
| Operating Revenue |
|
0.00
-76.61%
|
0.02
+261.17%
|
0.01
-64.17%
|
0.01
|
| Cost Of Revenue |
|
0.00
-69.08%
|
0.01
+117.49%
|
0.00
-64.56%
|
0.01
|
| Reconciled Cost Of Revenue |
|
0.00
-69.08%
|
0.01
+117.49%
|
0.00
-64.56%
|
0.01
|
| Gross Profit |
|
0.00
-80.27%
|
0.01
+431.82%
|
0.00
-63.69%
|
0.01
|
| Operating Expense |
|
8.36
+32.24%
|
6.32
+3.32%
|
6.12
+29.67%
|
4.72
|
| Research And Development |
|
4.39
+52.37%
|
2.88
+16.97%
|
2.46
-18.01%
|
3.00
|
| Selling General And Administration |
|
3.97
+15.38%
|
3.44
-5.88%
|
3.65
+113.17%
|
1.71
|
| Total Expenses |
|
8.36
+32.14%
|
6.32
+3.37%
|
6.12
+29.52%
|
4.72
|
| Operating Income |
|
-8.35
-32.46%
|
-6.31
-3.15%
|
-6.11
-29.80%
|
-4.71
|
| Total Operating Income As Reported |
|
-8.35
-32.46%
|
-6.31
-3.15%
|
-6.11
-29.80%
|
-4.71
|
| EBITDA |
|
-8.14
-32.18%
|
-6.16
-3.02%
|
-5.98
-34.89%
|
-4.43
|
| Normalized EBITDA |
|
-8.14
-32.18%
|
-6.16
-3.02%
|
-5.98
-27.68%
|
-4.68
|
| Reconciled Depreciation |
|
0.13
+34.50%
|
0.10
-29.77%
|
0.14
+409.87%
|
0.03
|
| EBIT |
|
-8.26
-32.21%
|
-6.25
-2.29%
|
-6.11
-37.12%
|
-4.46
|
| Total Unusual Items |
|
—
|
—
|
0.00
-100.00%
|
0.25
|
| Total Unusual Items Excluding Goodwill |
|
—
|
—
|
0.00
-100.00%
|
0.25
|
| Special Income Charges |
|
—
|
—
|
0.00
-100.00%
|
0.25
|
| Other Special Charges |
|
—
|
—
|
—
|
-0.25
|
| Net Income |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-31.61%
|
-4.83
|
| Pretax Income |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-31.61%
|
-4.83
|
| Net Non Operating Interest Income Expense |
|
-0.50
-41.34%
|
-0.35
-45.61%
|
-0.24
+34.56%
|
-0.37
|
| Interest Expense Non Operating |
|
0.50
+41.34%
|
0.35
+45.61%
|
0.24
-34.56%
|
0.37
|
| Net Interest Income |
|
-0.50
-41.34%
|
-0.35
-45.61%
|
-0.24
+34.56%
|
-0.37
|
| Interest Expense |
|
0.50
+41.34%
|
0.35
+45.61%
|
0.24
-34.56%
|
0.37
|
| Other Income Expense |
|
0.09
+60.67%
|
0.05
+2856.82%
|
0.00
-99.27%
|
0.25
|
| Other Non Operating Income Expenses |
|
0.09
+60.67%
|
0.05
+2856.82%
|
0.00
-27.76%
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-31.61%
|
-4.83
|
| Net Income From Continuing Operation Net Minority Interest |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-31.61%
|
-4.83
|
| Net Income From Continuing And Discontinued Operation |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-31.61%
|
-4.83
|
| Net Income Continuous Operations |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-31.61%
|
-4.83
|
| Normalized Income |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-25.12%
|
-5.08
|
| Net Income Common Stockholders |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-31.61%
|
-4.83
|
| Diluted EPS |
|
-9.34
+50.16%
|
-18.74
+76.58%
|
-80.00
-34.41%
|
-59.52
|
| Basic EPS |
|
-9.34
+50.16%
|
-18.74
+76.58%
|
-80.00
-34.41%
|
-59.52
|
| Basic Average Shares |
|
0.94
+166.16%
|
0.35
+343.39%
|
0.08
-1.99%
|
0.08
|
| Diluted Average Shares |
|
0.94
+166.16%
|
0.35
+343.39%
|
0.08
-1.99%
|
0.08
|
| Diluted NI Availto Com Stockholders |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-31.61%
|
-4.83
|
| Gain On Sale Of PPE |
|
—
|
—
|
—
|
0.00
|
| Line Item | Trend | 2023-04-30 |
|---|---|---|
| Total Assets |
|
3.29
|
| Current Assets |
|
2.70
|
| Cash Cash Equivalents And Short Term Investments |
|
1.66
|
| Cash And Cash Equivalents |
|
1.66
|
| Receivables |
|
0.00
|
| Accounts Receivable |
|
0.00
|
| Inventory |
|
0.68
|
| Raw Materials |
|
0.67
|
| Work In Process |
|
0.02
|
| Finished Goods |
|
0.03
|
| Prepaid Assets |
|
0.14
|
| Current Deferred Assets |
|
0.18
|
| Other Current Assets |
|
0.04
|
| Total Non Current Assets |
|
0.59
|
| Net PPE |
|
0.59
|
| Gross PPE |
|
1.06
|
| Accumulated Depreciation |
|
-0.47
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.10
|
| Other Properties |
|
0.93
|
| Leases |
|
0.03
|
| Goodwill And Other Intangible Assets |
|
0.00
|
| Total Liabilities Net Minority Interest |
|
3.06
|
| Current Liabilities |
|
1.83
|
| Payables And Accrued Expenses |
|
1.25
|
| Payables |
|
0.63
|
| Accounts Payable |
|
0.63
|
| Current Accrued Expenses |
|
0.62
|
| Current Debt And Capital Lease Obligation |
|
0.53
|
| Current Debt |
|
0.50
|
| Other Current Borrowings |
|
0.50
|
| Current Capital Lease Obligation |
|
0.03
|
| Other Current Liabilities |
|
0.05
|
| Total Non Current Liabilities Net Minority Interest |
|
1.22
|
| Long Term Debt And Capital Lease Obligation |
|
1.04
|
| Long Term Debt |
|
0.50
|
| Long Term Capital Lease Obligation |
|
0.54
|
| Stockholders Equity |
|
0.23
|
| Common Stock Equity |
|
0.23
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
0.10
|
| Ordinary Shares Number |
|
0.10
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
60.99
|
| Retained Earnings |
|
-60.76
|
| Total Equity Gross Minority Interest |
|
0.23
|
| Total Capitalization |
|
0.73
|
| Working Capital |
|
0.86
|
| Invested Capital |
|
1.23
|
| Total Debt |
|
1.57
|
| Net Debt |
|
—
|
| Capital Lease Obligations |
|
0.57
|
| Net Tangible Assets |
|
0.23
|
| Tangible Book Value |
|
0.23
|
| Interest Payable |
|
0.24
|
| Inventories Adjustments Allowances |
|
-0.04
|
| Non Current Accrued Expenses |
|
0.19
|
| Preferred Stock Equity |
|
0.00
|
| Line Item | Trend | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-7.41
-22.12%
|
-6.07
-5.14%
|
-5.77
-58.43%
|
-3.64
|
| Cash Flow From Continuing Operating Activities |
|
-7.41
-22.12%
|
-6.07
-5.14%
|
-5.77
-58.43%
|
-3.64
|
| Net Income From Continuing Operations |
|
-8.77
-32.70%
|
-6.61
-3.95%
|
-6.35
-31.61%
|
-4.83
|
| Depreciation Amortization Depletion |
|
0.13
+34.50%
|
0.10
-29.77%
|
0.14
+409.87%
|
0.03
|
| Depreciation |
|
0.13
+34.50%
|
0.10
-29.77%
|
0.14
+409.87%
|
0.03
|
| Amortization Cash Flow |
|
—
|
—
|
—
|
0.00
|
| Depreciation And Amortization |
|
0.13
+34.50%
|
0.10
-29.77%
|
0.14
+409.87%
|
0.03
|
| Amortization Of Intangibles |
|
—
|
—
|
—
|
0.00
|
| Other Non Cash Items |
|
0.46
-15.34%
|
0.54
+310.04%
|
0.13
-31.41%
|
0.19
|
| Stock Based Compensation |
|
0.25
-38.30%
|
0.41
+63.11%
|
0.25
+263.04%
|
0.07
|
| Operating Gains Losses |
|
—
|
—
|
—
|
-0.23
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
0.02
|
| Gain Loss On Sale Of PPE |
|
—
|
—
|
—
|
0.00
|
| Change In Working Capital |
|
0.52
+202.68%
|
-0.50
-870.66%
|
0.07
-94.18%
|
1.12
|
| Change In Receivables |
|
-0.00
|
0.00
-100.00%
|
0.00
+200.00%
|
-0.00
|
| Changes In Account Receivables |
|
-0.00
|
0.00
-100.00%
|
0.00
+200.00%
|
-0.00
|
| Change In Inventory |
|
-0.02
-144.70%
|
0.05
+2225.23%
|
-0.00
-102.90%
|
0.08
|
| Change In Prepaid Assets |
|
0.36
+50.89%
|
0.24
-38.58%
|
0.39
+431.92%
|
0.07
|
| Change In Payables And Accrued Expense |
|
-0.11
+53.39%
|
-0.24
+11.18%
|
-0.27
-122.24%
|
1.22
|
| Change In Accrued Expense |
|
0.02
+128.61%
|
-0.06
+81.08%
|
-0.31
-135.84%
|
0.87
|
| Change In Payable |
|
-0.13
+29.29%
|
-0.18
-584.31%
|
0.04
-89.46%
|
0.36
|
| Change In Account Payable |
|
-0.13
+29.29%
|
-0.18
-584.31%
|
0.04
-89.46%
|
0.36
|
| Change In Other Working Capital |
|
0.40
+177.76%
|
-0.52
-955.62%
|
0.06
+124.53%
|
-0.25
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
—
|
| Change In Other Current Liabilities |
|
-0.10
-250.51%
|
-0.03
+72.79%
|
-0.11
|
—
|
| Investing Cash Flow |
|
-0.03
+75.90%
|
-0.13
-584.24%
|
-0.02
-847.62%
|
-0.00
|
| Cash Flow From Continuing Investing Activities |
|
-0.03
+75.90%
|
-0.13
-584.24%
|
-0.02
-847.62%
|
-0.00
|
| Net PPE Purchase And Sale |
|
-0.00
+95.10%
|
-0.06
-252.06%
|
-0.02
-847.62%
|
-0.00
|
| Purchase Of PPE |
|
-0.00
+95.10%
|
-0.06
-252.06%
|
-0.02
-847.62%
|
-0.00
|
| Sale Of PPE |
|
—
|
—
|
—
|
—
|
| Capital Expenditure |
|
-0.03
+75.90%
|
-0.13
-584.24%
|
-0.02
-847.62%
|
-0.00
|
| Net Intangibles Purchase And Sale |
|
-0.03
+55.55%
|
-0.06
|
0.00
|
—
|
| Purchase Of Intangibles |
|
-0.03
+55.55%
|
-0.06
|
0.00
|
—
|
| Financing Cash Flow |
|
2.73
-73.57%
|
10.34
+58.29%
|
6.53
+70.12%
|
3.84
|
| Cash Flow From Continuing Financing Activities |
|
2.73
-73.57%
|
10.34
+58.29%
|
6.53
+70.12%
|
3.84
|
| Net Issuance Payments Of Debt |
|
1.59
+3621.04%
|
0.04
+110.70%
|
-0.40
-109.42%
|
4.23
|
| Issuance Of Debt |
|
1.85
+453.57%
|
0.33
|
0.00
-100.00%
|
4.73
|
| Repayment Of Debt |
|
-0.26
+9.39%
|
-0.29
+26.78%
|
-0.40
+20.35%
|
-0.50
|
| Long Term Debt Issuance |
|
1.85
+453.57%
|
0.33
|
0.00
-100.00%
|
4.73
|
| Long Term Debt Payments |
|
-0.26
+9.39%
|
-0.29
+26.78%
|
-0.40
+20.35%
|
-0.50
|
| Net Long Term Debt Issuance |
|
1.59
+3621.04%
|
0.04
+110.70%
|
-0.40
-109.42%
|
4.23
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Net Short Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Net Common Stock Issuance |
|
1.15
-88.86%
|
10.30
+83.14%
|
5.62
|
0.00
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
-100.00%
|
1.31
|
0.00
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
-0.39
|
| Changes In Cash |
|
-4.71
-213.56%
|
4.15
+458.76%
|
0.74
+281.05%
|
0.19
|
| Beginning Cash Position |
|
5.81
+249.76%
|
1.66
+80.83%
|
0.92
+26.92%
|
0.72
|
| End Cash Position |
|
1.10
-81.09%
|
5.81
+249.76%
|
1.66
+80.83%
|
0.92
|
| Free Cash Flow |
|
-7.44
-20.14%
|
-6.20
-6.97%
|
-5.79
-58.85%
|
-3.65
|
| Common Stock Issuance |
|
1.15
-88.86%
|
10.30
+83.14%
|
5.62
|
0.00
|
| Issuance Of Capital Stock |
|
1.15
-88.86%
|
10.30
+83.14%
|
5.62
|
0.00
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-03 View
- 8-K2026-03-16 View
- 10-Q2026-03-16 View
- 8-K2026-01-16 View
- 42026-01-12 View
- 42026-01-12 View
- 42025-12-22 View
- 42025-12-22 View
- 42025-12-22 View
- 8-K2025-12-16 View
- 8-K2025-12-15 View
- 10-Q2025-12-15 View
- 42025-11-28 View
- 8-K2025-11-28 View
- 8-K2025-10-01 View
- 8-K2025-09-17 View
- 8-K2025-09-11 View
- 10-Q2025-09-11 View
- 8-K2025-09-08 View
- 8-K2025-08-22 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|